Navigation Links
Cell Therapeutics Completes Type A Meeting With FDA's Division of Oncology Drug Products: Guidance Provided for Resubmission of Pixantrone NDA for Consideration of Accelerated Approval
Date:6/13/2011

SEATTLE, June 14, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today announced that it met with the U.S. Food and Drug Administration's (the "FDA") Division of Oncology Drug Products (the "DODP").  The meeting provided a pathway for re-submitting CTI's New Drug Application (the "NDA") for pixantrone for relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL") including the potential for accelerated approval based on the PIX301 study results. This meeting follows CTI's receipt of the FDA's Office of New Drugs' (the "OND") response to CTI's appeal as announced on May 3, 2011, which allows CTI the opportunity to resubmit the NDA. On appeal, the FDA recommended the Company conduct an additional review of radiographs utilizing a new independent panel of radiologists to confirm the response and progression events noted in the pixantrone NDA. The DODP meeting also focused on the documents CTI proposed to provide regarding the circumstances of stopping the enrollment of the clinical trial prior to achieving the original planned patient accrual and the make-up of the new radiology expert panel. CTI also plans to address items noted in the FDA's Complete Response Letter. The DODP confirmed that the NDA would be reviewed within six months from the resubmission of the NDA. CTI anticipates filing the additional information later this year, and could obtain FDA approval in the first half of 2012.

"We are pleased to have the opportunity to meet with the review team from the DODP and to get their feedback on what will be required for a resubmission of our pixantrone NDA. We now have a pathway to move forward with resubmitting the NDA for potential accelerated approval of pixantrone in patients with multiple relapsed or refractory aggressive NHL, which is a stage of this disease for which there are no approved agents," stated Jack W. Singer, M.D., Chief Medical Officer of CTI. "We are excited to have been given this rare second o
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
2. Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics
3. Healthpoint Biotherapeutics to Present at Upcoming Investment Conferences
4. Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
5. Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers
6. Precision Therapeutics Demonstrates Utility of Multi-Gene Predictors in Predicting Chemotherapy Response for Breast Cancer Patients
7. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
8. Echo Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference
9. Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA
10. Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics
11. Serina Therapeutics, Inc. Closes $9.5 Million Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014  Rock Creek Pharmaceuticals, Inc. (NASDAQ: ... that the Food and Drug Administration ("FDA"), has notified ... RCP,s Investigational New Drug ("IND") application before granting the ... US. Dr. Chris Chapman , RCP,s ... on our IND. When we receive the agency,s official ...
(Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
(Date:7/11/2014)... , July 11, 2014 Research and ... of the "Immunoprotein Diagnostic Testing Market - ... highest CAGR of 6% and is expected to ... to their offering. ... diagnostic testing has been segmented according to immunoprotein ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2
... . , April 30 A new study, presented at ... , found that Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring ... , , ... has been proven in several other studies to improve breast cancer detection ...
... April 29 Warner Chilcott plc (Nasdaq: WCRX ) announced ... market opening on Friday, May 7, 2010 . , ... In addition to issuing a press release, the Company will host a ... 8:00 AM (Eastern Time) to review the results. To participate in the ...
Cached Medicine Technology:BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy 2Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2010 Financial Results 2
(Date:7/13/2014)... The report “Micronutrient Market by Type (Zinc, ... Non Chelated), Application Mode (Soil, Foliar, Fertigation), Crop ... to 2018” defines and segments the global agriculture ... the global value and volume for agriculture micronutrients. ... for the global agriculture micronutrients market with an ...
(Date:7/13/2014)... 13, 2014 MarketsandMarkets recently conducted ... Modeling; 3D Scanning; 3D rendering; Layout and Animation; ... (2013 - 2018)”, which analyzes and studies the ... America, Western Europe, Eastern Europe, Middle East and ... draws the competitive landscape of the 3D imaging ...
(Date:7/13/2014)... WA (PRWEB) July 13, 2014 Athletes ... longer recovery period from concussions, according to research presented ... ( AOSSM ) Annual Meeting. The research marks the ... concussion based on the known physical events that occur ... patients with a long allele in the (GT)n genotype ...
(Date:7/13/2014)... July 13, 2014 Recently, MyDressCity.com, one ... women’s special occasion outfits, has released its new range ... the new products are available at discounted prices. Worldwide ... 2014. , In the company’s online shop, there ... of them are made with great materials. MyDressCity.com’s hot ...
(Date:7/13/2014)... COPENHAGEN, July 13, 2014 A decreased ability ... cognitive impairment and Alzheimer,s disease, while examinations of ... a protein associated with Alzheimer,s, in the brain, ... reported today at the Alzheimer,s Association International Conference ... of the studies, the decreased ability to identify ...
Breaking Medicine News(10 mins):Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7
... KR ) said today,it is recalling Private Selection Peanut ... butter in the ice cream was supplied by,Peanut Corporation of ... following names are included in this recall: City Market, ... Stores the company operates under the following names ...
... factors are just as reliable, researchers say, , , MONDAY, ... variation is associated with an increased risk for heart ... who is likely to get heart disease any more ... , There has been continuing excitement in recent years ...
... early-stage lung cancer are not seen when patients are ... January issue of Archives of Surgery , one ... deaths in the United States than any other cancer, ... surgery to remove a portion of the lungprovides the ...
... received recommended care did better, regardless of race, study ... disparities between white and black patients with early-stage lung ... to a U.S. study that included nearly 18,000 patients. ... lung (pulmonary resection) provides the best chance of a ...
... of blood pressure, other factors may be boosting survival, ... First-time heart attacks in the United States aren,t as ... a long-running study finds. , "We know that deaths ... Meyerson, director of the cardiovascular disease prevention program at ...
... specializing in healthcare services at Affiliated Computer Services, Inc. ... highest ranking in a national survey for the second ... place award for its work in the Financial Enterprise ... Top 20 Best in KLAS Awards: Software & Professional ...
Cached Medicine News:Health News:Kroger Recalls Select Ice Cream Products Due to Possible Health Risk 2Health News:Genetic Data May Not Boost Heart Disease Predictions 2Health News:Study examines racial disparities in survival among patients diagnosed with lung cancer 2Health News:Optimal Treatment Boosts Blacks' Lung Cancer Survival 2Health News:U.S. Heart Attacks Becoming Less Severe 2Health News:U.S. Heart Attacks Becoming Less Severe 3Health News:ACS is 'Best in KLAS' for Healthcare Financial Implementation Services for Second Consecutive Year 2Health News:ACS is 'Best in KLAS' for Healthcare Financial Implementation Services for Second Consecutive Year 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: